24 research outputs found

    Synthesis of glycoconjugates by human diseased veins: modulation by procyanidolic oligomers

    No full text
    Venous diseases become steadily more common and severe with age, and are often accompanied by venous lymphatic oedema. We have investigated the role of glycoconjugates in this disorder and the action of procyanidols used to treat these diseases. Explants of vein wall from patients with or without venous lymphatic oedema were cultured for 24 hours and the incorporation of radioactive glucosamine into total glycoconjugates and into hyaluronan was measured. The explants from patients with oedema incorporated more glucosamine than those without oedema (+42% expressed as c.p.m./mg dry weight into total glycosaminoglycans and +12% expressed as c.p.m./mg dry weight into hyaluronan). The explants from oedematous patients secreted less glycoconjugates into the culture medium than those from non-oedematous veins (−63% of total incorporated radioactivity into hyaluronan and −66% into hyaluronidase-resistent glycoconjugates). Explants placed in medium containing procyanidols (1 mg/ml, 2.8 m m) incorporated less glucosamine (−19%) and secreted more into the medium (+119%). Glycoprotein and sulphated glycosaminoglycan synthesis were mainly affected which may well explain the beneficial effect of procyanidols on vein disorders

    <title>Corneal photoablation with a scanning beam of 213 nm radiation for alteration of refraction: a three-month follow up study of the rabbit</title>

    No full text
    A scanning pulsed beam at 213 nm creates predictable correction of myopia but the surgical procedure with the presently used laser system is not yet sufficiently safe to proceed to human clinical trials. It was found that a 70% overlap of approximate active spot size provides a refractive change as predicted 1 week after ablation. There was a minimal transient increase of IOP shortly after the ablation. There was an immediate swelling of the cornea after the ablation that gradually decreased during the following 12 weeks. The corneal epithelium did not heal until around 4 - 7 weeks after the ablation. The epithelium stained with fluorescein late after the ablation. When considerable haze was seen it decreased towards the end of the 12 weeks of observation. Approximately 30% of ablated corneas showed vessel ingrowth at 12 weeks after ablation. The 213 nm beam was obtained by frequency quintupling of the output of a Nd-Yag laser. The beam was moved with an X-Y scanner

    Three month follow-up of changes in the rabbit cornea after photoablation with a pulsed scanning beam at 213 nm

    No full text
    A scanning beam of nano-second pulses at 213 nm flattens the cornea as predicted. However, there is a considerable variability in the flattening and the ablation is not safe. Ablation for 16 D flattening with an active spot overlap of 50% induced 8.9 +/- 5.3 D (n equals 7) as measured by the TMS topography system (ring 7 average) and 5.8 +/- 4.1 D (n equals 5) as measured with the SK-1 (2 mm zone) system. Ablation for 6 D flattening with an active spot overlap of 70% induced approximately 2 D flattening to 2 D steepening (n equals 3) as measured with the TMS (ring 7) and 6.6 +/- 4.33 D (n equals 7) flattening as measured by SK-1 (2 mm zone) keratometry. There was no change in IOP at 12 weeks after as compared to before ablation. There was a net increase of central and peripheral corneal thickness at 12 weeks after the ablation as compared to preoperatively. Epithelial defects remained up to 4 weeks after ablation. After four weeks, vessels had invaded the cornea in 30% of the cases and remained throughout the three months observed. It is concluded that 213 nm nano-second pulses can be used for flattening the cornea but the system should not be used for clinical trials in humans until the adverse effects can be avoided
    corecore